leisure time -WSS

leisure time

author：explore 2025-09-30 21:27:15 - browse：36

A screen at the New York Stock Exchange last November. Michael M. Santiago/Getty Images

Pfizer spent more than four hours Thursday laying out its oncology program to investors. But the company also spent some time talking about the effects of the Inflation Reduction Act on its pipeline.

The drug giant, which is facing investor dissatisfaction after a year in which its stock dropped 44%, said it would be focusing on drugs that are based on proteins, not small molecule pills as it has traditionally developed. (Pfizer’s current best-seller in oncology, Ibrance for breast cancer, is a small molecule pill.) It said the mix of small molecule drugs in its cancer portfolio will drop from 94% last year to 35% in 2030.

That matters because small molecules are more vulnerable to generic competition and the Medicare price negotiation introduced by the IRA. Suneet Varma, the commercial president of Pfizer’s oncology unit, said “this planned shift to biologics is expected to support the accelerated growth in both the top and bottom line,” referring to the revenue and profit lines of a balance sheet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： John Green on his newest strategy for fighting tuberculosis

hotspot

WSS

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Why scientists need input from humanists on sensitive research

Stanford president’s abrupt resignation sparks debate

Hormonal contraceptives don’t actually treat endometriosis

UCLA team creates talking throat patch for voice disorders

First U.S. drug developed to treat liver disease MASH is approved

focus

leisure time

knowledge

Supreme Court strikes down use of affirmative action

Sanders wants to replace patents with prizes for drug inventions

Medicare details structure of new drug price negotiation program

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Sports medicine is finally prioritizing gender equality

FDA advisers back CAR

DIEP, the 'gold standard' of breast reconstruction, is under threat

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Why scientists need input from humanists on sensitive research

explore

Scientists grapple with ethics of stem cell research

HHS secretary Becerra pressed on Change HealthCare cyberattack

UCLA team creates talking throat patch for voice disorders

Delta passengers in Vegas fall sick while waiting on flight in triple

HHS secretary Becerra pressed on Change HealthCare cyberattack

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

leisure time

hotspot

focus

leisure time